Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
Go back to Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia| Diversified Corporate Resources, Inc. (NASDAQ: IRD) | Delayed: 3.59 -0.23 (6.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.82 | 52 Week High | $0.02 | |||
| Open | $3.79 | 52 Week Low | $0.02 | |||
| Day High | $3.83 | P/E | N/A | |||
| Day Low | $3.56 | EPS | $0.00 | |||
| Volume | 335,423 | |||||



